DermatologicSpyre initiates SPY-772 program in hidradenitis suppurativaSpyre Therapeutics Inc. has announced the launch of SPY-772, a new combination program comprising SPY-072, a long-acting anti-TL1A antibody, and SPY-007, a novel long-acting anti-IL-17A/F antibody in preclinical development.